WO2008138591A3 - Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses - Google Patents

Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses Download PDF

Info

Publication number
WO2008138591A3
WO2008138591A3 PCT/EP2008/003838 EP2008003838W WO2008138591A3 WO 2008138591 A3 WO2008138591 A3 WO 2008138591A3 EP 2008003838 W EP2008003838 W EP 2008003838W WO 2008138591 A3 WO2008138591 A3 WO 2008138591A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparing
processes
bicyclic
heterobicyclic derivatives
heterobicyclic
Prior art date
Application number
PCT/EP2008/003838
Other languages
French (fr)
Other versions
WO2008138591A2 (en
Inventor
Richard John Davenport
Andrew James Ratcliffe
Mark William Jones
Original Assignee
Ucb Pharma Sa
Richard John Davenport
Andrew James Ratcliffe
Mark William Jones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0709217A external-priority patent/GB0709217D0/en
Application filed by Ucb Pharma Sa, Richard John Davenport, Andrew James Ratcliffe, Mark William Jones filed Critical Ucb Pharma Sa
Publication of WO2008138591A2 publication Critical patent/WO2008138591A2/en
Publication of WO2008138591A3 publication Critical patent/WO2008138591A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention concerns bicyclic and heterobicyclic derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
PCT/EP2008/003838 2007-05-14 2008-05-13 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses WO2008138591A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0709217.4 2007-05-14
GB0709217A GB0709217D0 (en) 2007-05-14 2007-05-14 Bicyclc and heterobicyclic derivatives, proccesses for preparing them and their uses
EP07012331 2007-06-23
EP07012331.0 2007-06-23

Publications (2)

Publication Number Publication Date
WO2008138591A2 WO2008138591A2 (en) 2008-11-20
WO2008138591A3 true WO2008138591A3 (en) 2009-03-05

Family

ID=39739664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/003838 WO2008138591A2 (en) 2007-05-14 2008-05-13 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses

Country Status (1)

Country Link
WO (1) WO2008138591A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174256B2 (en) * 2018-10-30 2021-11-16 Gilead Sciences, Inc. Imidazopyridine derivatives
AU2020329207B2 (en) * 2019-08-14 2024-02-29 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006918A1 (en) * 2002-07-17 2004-01-22 Celltech R & D Limited Phenylalanine enamide derivatives containing a spiro`3.5!non-1-ene ring for use as integrin inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006918A1 (en) * 2002-07-17 2004-01-22 Celltech R & D Limited Phenylalanine enamide derivatives containing a spiro`3.5!non-1-ene ring for use as integrin inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LINUS S. LIN ET AL: "Bioisosteric replacements of anilide with benzoxazole: potent and orally bioavailable antagonist of VLA-4", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 9, 2004, pages 2331 - 2334, XP002464075 *

Also Published As

Publication number Publication date
WO2008138591A2 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
EP2308867A3 (en) 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
WO2007065595A3 (en) Xanthine derivatives, processes for preparing them and their uses
TN2011000245A1 (en) Organic compounds
WO2008132139A3 (en) New heterocyclic derivatives useful for the treatment of cns disorders
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2251038A4 (en) Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
WO2009156462A3 (en) Organic compounds
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
WO2008121767A3 (en) Stitched polypeptides
IL221952A (en) 2,3-dihydro-1h-inden-1-yl-2,7- diazaspiro[3.5] nonane derivatives and pharmaceutical compositions comprising the same
WO2010117738A3 (en) Solid state forms of sitagliptin salts
TW200800967A (en) Benzimidazole thiophene compounds
IL206808A (en) Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
TN2012000147A1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
PL2231598T3 (en) Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
ZA200902414B (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
WO2007071444A3 (en) Esomeprazole arginine
WO2009007747A3 (en) Hydantoin derivatives used as mmp12 inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08749446

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08749446

Country of ref document: EP

Kind code of ref document: A2